This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cardinali, C. Articles by Fabbri, P. Search for Related Content PubMed PubMed Citation Articles by Cardinali, C. Articles by Fabbri, P. Social Bookmarking                         What's this?

The composition of the lupus band test (LBT) on the sun-protected non-lesional (SPNL) skin in patients with cutaneous lupus erythematosus (CLE)

Department of Dermatology, University of Florence, Italy; Clinica Dermatologica II, UniversitA degli Studi di Firenze, Via della Pergola 58, 50121 Firenze, Italy; Fabbri~cesitl.unifi.it

Marzia Caproni

Paolo Fabbri

Department of Dermatology, University of Florence, Italy

The objective of this study was to analyse the different immunoreactants at the dermo-epidermal junction (DEJ) of patients with cutaneous lupus erythematosus (CLE). Sun-protected non lesional (SPNL) skin biopsies from 65 patients with specific cutaneous manifestations of LE and from 18 patients with other dermatologic diseases were tested using the direct immunofluorescence (DIF) technique. Nineteen out of 65 patients with CLE were affected by systemic LE (SLE). We used the conventional chi-squared test to analyse statistical differences between CLE-SLE and CLE-non-SLE groups in the immunological composition of lupus band test (LBT). C₃ was the most common component while IgM were the most frequent immunoglobulins (Igs) of LBT in LE patients. No immunoreactants could be demonstrated at the DEJ in patients with other dermatologic diseases. No statistical differences could be found between CLE-SLE and CLE-non-SLE groups as regards the detection of the different immunoreactants at the DEJ. A positive LBT (even for the presence of only one immunoreactant at the DEJ) performed on SPNL skin represents a useful and specific criterion to distinguish patients with lupus erythematosus (LE) from those without LE. We also believe in a prognostic value of a positive LBT on SPNL skin when the deposition of at least two immunoreactants is demonstrated, and especially if the deposits are composed of IgG.

Key Words: lupus erythematosus (LE) • lupus band test (LBT) • sun-protected non-lesional (SPNL) skin • antinuclear antibodies (ANA) • immunoglobulins

Lupus, Vol. 8, No. 9, 755-760 (1999)
DOI: 10.1191/096120399678840945


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P Fabbri, L Amato, C Chiarini, S Moretti, and D Massi Scarring alopecia in discoid lupus erythematosus: a clinical, histopathologic and immunopathologic study Lupus, June 1, 2004; 13(6): 455 - 462. [Abstract] [PDF]